Holen Sie sich die Stockscreener-App
37.86
1.97%
0.71
Handel nachbörslich:
37.86
Schlusskurs vom Vortag:
$37.15
Offen:
$36.94
24-Stunden-Volumen:
1.32M
Relative Volume:
1.44
Marktkapitalisierung:
$4.26B
Einnahmen:
$14.09M
Nettoeinkommen (Verlust:
$-176.94M
KGV:
-17.61
EPS:
-2.15
Netto-Cashflow:
$-141.24M
1W Leistung:
+17.60%
1M Leistung:
+56.59%
6M Leistung:
+130.69%
1J Leistung:
+97.70%
1-Tages-Spanne:
$36.16
$38.79
1-Wochen-Bereich:
$31.54
$39.76
52-Wochen-Spanne:
$14.06
$39.76
Newamsterdam Pharma Company Nv Stock (NAMS) Company Profile
Firmenname
Newamsterdam Pharma Company Nv
Sektor
Branche
Telefon
35 206 2971
Adresse
GOOIMEER 2-35, NARRDEN
Vergleichen Sie NAMS mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
NAMS
Newamsterdam Pharma Company Nv
|
37.86 | 4.18B | 14.09M | -176.94M | -141.24M | -2.15 |
|
VRTX
Vertex Pharmaceuticals Inc
|
412.22 | 104.45B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
469.36 | 60.95B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
572.60 | 59.11B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
812.95 | 49.23B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
320.94 | 35.92B | 4.56B | -176.77M | 225.30M | -1.7177 |
Newamsterdam Pharma Company Nv Stock (NAMS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-08-25 | Eingeleitet | Wells Fargo | Overweight |
| 2025-07-17 | Eingeleitet | Goldman | Neutral |
| 2025-06-17 | Eingeleitet | Citigroup | Buy |
| 2025-06-10 | Eingeleitet | Stifel | Buy |
| 2025-06-04 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2024-12-30 | Eingeleitet | H.C. Wainwright | Buy |
| 2024-05-15 | Eingeleitet | TD Cowen | Buy |
| 2024-03-14 | Eingeleitet | Scotiabank | Sector Outperform |
| 2024-01-18 | Eingeleitet | Guggenheim | Buy |
| 2024-01-16 | Eingeleitet | Piper Sandler | Overweight |
| 2023-10-30 | Eingeleitet | RBC Capital Mkts | Outperform |
Alle ansehen
Newamsterdam Pharma Company Nv Aktie (NAMS) Neueste Nachrichten
Caristo Chosen by Leading Pharma Company as Worldwide Imaging Core Lab to Measure Coronary Plaque and Inflammation (2025-10-14) - Seeking Alpha
Is NewAmsterdam Pharma Company N.V. Equity Warrant stock a top pick in earnings seasonJuly 2025 Institutional & Weekly Breakout Watchlists - newser.com
How to track smart money flows in NewAmsterdam Pharma Company N.V. Equity WarrantPortfolio Performance Summary & Community Driven Trade Alerts - newser.com
Published on: 2025-10-14 03:09:18 - newser.com
Can technical indicators confirm NewAmsterdam Pharma Company N.V. Equity Warrant’s reversal2025 Trading Volume Trends & Weekly High Potential Alerts - newser.com
Is NewAmsterdam Pharma Company N.V. stock a good choice for value investorsEarnings Recap Report & Weekly Watchlist for Consistent Profits - newser.com
Real time alert setup for NewAmsterdam Pharma Company N.V. Equity Warrant performanceJuly 2025 Setups & Step-by-Step Trade Execution Guides - newser.com
Why NewAmsterdam Pharma Company N.V. Equity Warrant stock attracts global investorsJuly 2025 Short Interest & Weekly Stock Performance Updates - newser.com
Tools to assess NewAmsterdam Pharma Company N.V.’s risk profile2025 Price Action Summary & Smart Investment Allocation Tips - newser.com
Technical analysis overview for NewAmsterdam Pharma Company N.V. Equity Warrant stockMarket Performance Summary & Accurate Trade Setup Notifications - newser.com
NewAmsterdam Pharma Company N.V. recovery potential after sell offM&A Rumor & Stock Portfolio Risk Control - newser.com
Is NewAmsterdam Pharma Company N.V. Equity Warrant forming a bottoming baseEarnings Growth Summary & Low Drawdown Investment Ideas - newser.com
Is it too late to sell NewAmsterdam Pharma Company N.V. Equity WarrantEarnings Beat & High Conviction Buy Zone Picks - newser.com
Will earnings trigger a reversal in NewAmsterdam Pharma Company N.V.Recession Risk & Fast Exit/Entry Strategy Plans - newser.com
Published on: 2025-10-13 07:22:45 - newser.com
Can NewAmsterdam Pharma Company N.V. stock resist sector downturns2025 Performance Recap & Community Trade Idea Sharing - newser.com
Published on: 2025-10-12 22:17:07 - newser.com
What Insider Transactions Reveal About Hindusthan Urban Infrastructure Limiteds OutlookReal-Time Stock Alerts & Free Powerful Profit Generation - earlytimes.in
NewAmsterdam Pharma (NASDAQ:NAMS) Hits New 12-Month HighHere's Why - MarketBeat
NewAmsterdam Pharma (NAMS) Stock Soars on Cholesterol Drug Breakthrough – What Investors Should Know - ts2.tech
NAMS Stock Surge: What Lies Ahead? - timothysykes.com
NewAmsterdam Pharma (NASDAQ:NAMS) Given "Sell (D-)" Rating at Weiss Ratings - MarketBeat
Why NewAmsterdam Pharma (NAMS) Is Up 7.5% After Late-Stage Obicetrapib Trial Optimism - Yahoo Finance
NewAmsterdam Pharma Company N.V. Equity Warrant stock trend forecastMarket Sentiment Review & Weekly High Conviction Trade Ideas - newser.com
Exit strategy if you’re trapped in NewAmsterdam Pharma Company N.V. Equity WarrantEarnings Beat & Reliable Price Breakout Signals - newser.com
Is this a good reentry point in NewAmsterdam Pharma Company N.V.Weekly Stock Analysis & Smart Investment Allocation Insights - newser.com
Custom watchlist performance reports with NewAmsterdam Pharma Company N.V.Weekly Market Report & Daily Technical Forecast Reports - newser.com
NewAmsterdam Pharma Company N.V. stock momentum explainedTrend Reversal & AI Enhanced Execution Alerts - newser.com
Topper, director at NewAmsterdam Pharma, buys $31,487 in shares By Investing.com - Investing.com Nigeria
Knights of Columbus Asset Advisors LLC Invests $595,000 in NewAmsterdam Pharma Company N.V. $NAMS - MarketBeat
NewAmsterdam Pharma Hits New 52-Week High of $34.62 - Markets Mojo
NewAmsterdam Pharma Company N.V. (NAMS) Soars 5.9%: Is Further Upside Left in the Stock? - Nasdaq
Newamsterdam Pharma stock hits 52-week high at 31.96 USD By Investing.com - Investing.com Canada
NewAmsterdam Pharma (NASDAQ:NAMS) Stock Price Up 8.8%Here's Why - MarketBeat
NewAmsterdam Pharma Co. Hits New 52-Week High of USD 31.81 - Markets Mojo
Is NewAmsterdam Pharma Company NV a good long term investmentRSI Overbought/Oversold & Exceptional Profit Trading - earlytimes.in
Newamsterdam Pharma stock hits 52-week high at 31.96 USD - Investing.com
Will NewAmsterdam Pharma Company N.V. (KH6) stock beat Nasdaq index returnsQuarterly Earnings Summary & Target Return Focused Stock Picks - newser.com
Institutional scanner results for NewAmsterdam Pharma Company N.V.Portfolio Risk Report & Entry Point Confirmation Alerts - newser.com
How NewAmsterdam Pharma Company N.V. stock performs in weak economyWeekly Stock Summary & Smart Money Movement Alerts - newser.com
Published on: 2025-10-05 03:30:23 - newser.com
NewAmsterdam Pharma Company N.V. Equity Warrant stock retracement – recovery analysisStock Surge & Real-Time Market Sentiment Alerts - newser.com
NewAmsterdam Pharma Co. NV Hits New 52-Week High at $29.66 - Markets Mojo
Exit strategy if you’re trapped in NewAmsterdam Pharma Company N.V.July 2025 Setups & Verified Technical Signals - newser.com
Can you recover from losses in NewAmsterdam Pharma Company N.V.Quarterly Performance Summary & Daily Market Momentum Tracking - newser.com
How NewAmsterdam Pharma Company N.V. (KH6) stock moves on employment dataJuly 2025 Volume & Free Technical Confirmation Trade Alerts - newser.com
Published on: 2025-10-02 23:50:02 - newser.com
Using data tools to time your NewAmsterdam Pharma Company N.V. exitEarnings Growth Report & Risk Adjusted Buy/Sell Alerts - newser.com
Is NewAmsterdam Pharma Company N.V. stock reversal real or fakeJuly 2025 Trends & Stock Portfolio Risk Management - newser.com
NewAmsterdam Pharma Provides Corporate Update and Reports First Quarter Financial Results - ADVFN
NewAmsterdam Pharma Provides Corporate Update and Reports Second Quarter Financial Results - ADVFN
Finanzdaten der Newamsterdam Pharma Company Nv-Aktie (NAMS)
Umsatz
Nettogewinn
Free Cashflow
ENV
5.47%
1.59%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):